SlideShare ist ein Scribd-Unternehmen logo
1 von 116
DRUG ABUSE  GROUP MEMBERS: AHMAD ABID ABAS [2] AHMAD ASYRAF MOHAMAD [3] AHMAD DANIAL AHMAD FUAD [5] AHMAD FARABI AB MANAF [7] ADIBA MD ZAIN [8] ADIBAH ABDUL JABAR [9] KHAIREZA KHAIRUDIN [10] ASIF AMRI HUSSIN [11]
BY:ASIF AMRI BIN HUSSIN (07-5-11)
OVERVIEW ,[object Object],[object Object]
[object Object]
DEFINITION OF DRUG ABUSE ,[object Object]
[object Object]
STATISTICS OF DRUG ABUSE IN MALAYSIA ,[object Object],[object Object]
[object Object],[object Object]
[object Object]
[object Object]
This map shows the Malaysia and it’s states.
The following table illustrates the number of drug abuse in Malaysia by states from January to June 2011 and the differences in the number for the same period during 2010.
This table shows the number of drug abuser in Malaysia from January to June 2011 and the differences of the numbers in the same months from the last year.
[object Object],[object Object],[object Object]
[object Object],[object Object]
The table above shows the number of drug abuser according to the job and the differences in number compared to 2010 statistics.
 
[object Object],[object Object],[object Object]
[object Object],[object Object]
FACTORS ASSOCIATED WITH DRUG ABUSE by: AHMAD DANIAL BIN AHMAD FUAD,5
INTRODUCTION ,[object Object],[object Object],[object Object]
 
 
genetic ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
The A1 allele of the dopamine receptor gene  DRD2  is more common in people addicted to alcohol or cocaine Increased expression of the  Mpdz  gene results in mice experiencing less severe withdrawal symptoms from sedative-hypnotic drugs such as barbiturates Mice bred to lack the cannabinoid receptor gene  Cnr1  have a reduced reward response to morphine . Mice bred to lack the serotonin receptor gene Htr1b  are more attracted to cocaine and alcohol Mice bred to lack the β2 subunit of nicotinic cholinergic receptors have a reduced reward response to cocaine Mice with low levels of neuropeptide Y drink more alcohol, whereas those with higher levels tend to abstain Fruit flies mutated to be unable to synthesize tyramine remain sedate even after repeated doses of cocaine Mice mutated with a defective Per2  gene drink three times more alcohol than normal Non-smokers are more likely than smokers to carry a protective gene,  CYP2A6 , which causes them to feel more nausea and dizziness from smoking Alcoholism is rare in people with two copies of the  ALDH*2  gene variation Mice with the  Creb  gene "knocked-out" are less likely to develop morphine dependence.
OTHER FACTORS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
conclusion ,[object Object],[object Object]
CLASSIFICATIONS OF DRUG ABUSE
Cannabinoids and hallucinogens By: Ahmad Asyraf bin Mohamed (3)
Cannabinoids ,[object Object],[object Object],[object Object]
 
Mechanism of action ,[object Object],[object Object],[object Object],[object Object]
[object Object]
Effects ,[object Object],[object Object],[object Object],[object Object],[object Object]
More effects ,[object Object],[object Object],[object Object],[object Object]
Withdrawal ,[object Object],[object Object],[object Object],[object Object]
Hallucinogens ,[object Object],[object Object],[object Object],[object Object]
Tablets of MDMA
Mechanism of action ,[object Object],[object Object],[object Object]
Effects of LSD ,[object Object],[object Object],[object Object]
 
Effects of MDMA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adverse effects ,[object Object],[object Object],[object Object],[object Object],[object Object]
Withdrawal symptoms ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
References  ,[object Object],[object Object],[object Object]
AMPHETAMINES ADDICTION By : ADIBAH ABDUL JABAR (9)
Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]
Effects of abuse ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object]
 
Withdrawal symptoms ,[object Object],[object Object],[object Object],[object Object],[object Object]
Tobacco and Inhalants Ahmad Abid Abas  2
Tobacco ,[object Object],[object Object],[object Object],[object Object],[object Object]
Tobacco  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adverse Effects on Health
Tobacco Free Initiative (WHO)
WHO response ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Malaysian Smoking Cessation Programme and Smoke-Free Air Laws
Inhalants  –Who’s Huffing Now (glue and gums sniffing)-(whippets,poppers,snappers) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Inhalants  (Mechanism affect brain) ,[object Object],[object Object],[object Object]
Inhalants  (symptoms of intoxication) ,[object Object],[object Object],[object Object],[object Object]
Inhalants  (withdrawal symptoms) ,[object Object],[object Object],[object Object]
Adverse Effect on Health ,[object Object],[object Object],[object Object],[object Object]
 
 
 
From to ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
 
Beer Hard  Liquor Wine ,[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
A blood toxicology screen can determine the presence and level (amount) of a drug in your body. Urine sample results are usually reported as positive (substance is found) or negative (no substance is found).
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DRUGS DURATION OF DETECTION IN URINE: Alcohol up to 1 day Amphetamines (including MDMA, MDA) 1-3 days Barbiturates 1-3 days Benzodiazepines 1-3 days Cannabis up to 14 days Cocaine 1-3 days Codeine 1-2 days Cyclizine 1-2 days Dihydrocodeine 1-2 days Heroin (morphine) up to 1 day Methadone 1-3 days 6-MAM up to 1 day
[object Object],[object Object],[object Object],[object Object],[object Object]
PRINCIPLE AND METHODS OF TREATMENT BY: ADIBA MD ZAIN [8]
PRINCIPLES OF EFFECTIVE TREATMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
 
DETOXIFICATION ,[object Object],[object Object],[object Object]
Outpatient Drug Rehabs and Drug Treatment Centers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Inpatient Short-Term   Drug Rehabs and Drug Treatment Centers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Inpatient Long-Term   Drug Rehabs and Drug Treatment Centers ,[object Object],[object Object],[object Object],[object Object],[object Object]
REHABILITATION CENTER
 
Prepared By: AHMAD FARABI BIN AB MANAF (7) PHARMACOTHERAPY FOR ADDICTIVE DISORDER
 
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
 
[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Drug abuse and addiction
Drug abuse and addictionDrug abuse and addiction
Drug abuse and addiction
Mada Nambis
 
Drugs: Examples, Types, and Reasons etc.
Drugs: Examples, Types, and Reasons etc.Drugs: Examples, Types, and Reasons etc.
Drugs: Examples, Types, and Reasons etc.
Jessa may burila
 
Depressant PowerPoint
Depressant PowerPointDepressant PowerPoint
Depressant PowerPoint
allenkay26
 
Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse ppt
DFC2011
 
Psychoactive Drugs
Psychoactive DrugsPsychoactive Drugs
Psychoactive Drugs
Harve Abella
 
B1.3 use and abuse of drugs
B1.3 use and abuse of drugsB1.3 use and abuse of drugs
B1.3 use and abuse of drugs
Steve Bishop
 

Was ist angesagt? (20)

Drug abuse and addiction
Drug abuse and addictionDrug abuse and addiction
Drug abuse and addiction
 
Drugs: Examples, Types, and Reasons etc.
Drugs: Examples, Types, and Reasons etc.Drugs: Examples, Types, and Reasons etc.
Drugs: Examples, Types, and Reasons etc.
 
Depressant PowerPoint
Depressant PowerPointDepressant PowerPoint
Depressant PowerPoint
 
Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse ppt
 
DRUG ABUSE
DRUG ABUSEDRUG ABUSE
DRUG ABUSE
 
Drug addiction
Drug addictionDrug addiction
Drug addiction
 
Presentation drugs
Presentation drugsPresentation drugs
Presentation drugs
 
Psychoactive Drugs
Psychoactive DrugsPsychoactive Drugs
Psychoactive Drugs
 
Drug abuse prathyusha
Drug abuse prathyushaDrug abuse prathyusha
Drug abuse prathyusha
 
Drug Abuse and Addiction among Nigerian Youth
Drug Abuse and Addiction among Nigerian YouthDrug Abuse and Addiction among Nigerian Youth
Drug Abuse and Addiction among Nigerian Youth
 
"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER
 
B1.3 use and abuse of drugs
B1.3 use and abuse of drugsB1.3 use and abuse of drugs
B1.3 use and abuse of drugs
 
Drug Addiction
Drug AddictionDrug Addiction
Drug Addiction
 
Drug and Substance Abuse Orientation
Drug and Substance Abuse OrientationDrug and Substance Abuse Orientation
Drug and Substance Abuse Orientation
 
D ru g addiction
D ru g addictionD ru g addiction
D ru g addiction
 
Drug abuse
Drug abuseDrug abuse
Drug abuse
 
Substance abuse edited!
Substance abuse edited!Substance abuse edited!
Substance abuse edited!
 
Drug addiction
Drug addictionDrug addiction
Drug addiction
 
Drug abuse
Drug abuseDrug abuse
Drug abuse
 
Life of Youth and Drug Addiction
Life of Youth and Drug AddictionLife of Youth and Drug Addiction
Life of Youth and Drug Addiction
 

Ähnlich wie Drug Abuse and Addiction

Chapter15 Power Point Presentation
Chapter15 Power Point PresentationChapter15 Power Point Presentation
Chapter15 Power Point Presentation
Gladys Escalante
 

Ähnlich wie Drug Abuse and Addiction (20)

BPE MODULE 3 STUDENTS.pdf
BPE MODULE 3 STUDENTS.pdfBPE MODULE 3 STUDENTS.pdf
BPE MODULE 3 STUDENTS.pdf
 
Ch 5 Drugs
Ch 5 DrugsCh 5 Drugs
Ch 5 Drugs
 
DRUGS : PROBLEM OF THE WORLD
DRUGS : PROBLEM OF THE WORLDDRUGS : PROBLEM OF THE WORLD
DRUGS : PROBLEM OF THE WORLD
 
DRUG ABUSE PREVENTION PRESENTATION
DRUG ABUSE PREVENTION PRESENTATIONDRUG ABUSE PREVENTION PRESENTATION
DRUG ABUSE PREVENTION PRESENTATION
 
Ccps anti drug campaign
Ccps anti drug campaignCcps anti drug campaign
Ccps anti drug campaign
 
Brain Science
Brain ScienceBrain Science
Brain Science
 
Drug abuse and addition
Drug abuse and additionDrug abuse and addition
Drug abuse and addition
 
drugabusepresentaton-1-150512021741-lva1-app6892 (1).pptx
drugabusepresentaton-1-150512021741-lva1-app6892 (1).pptxdrugabusepresentaton-1-150512021741-lva1-app6892 (1).pptx
drugabusepresentaton-1-150512021741-lva1-app6892 (1).pptx
 
Chapter15 Power Point Presentation
Chapter15 Power Point PresentationChapter15 Power Point Presentation
Chapter15 Power Point Presentation
 
Substance Abuse and Addiction
Substance Abuse and AddictionSubstance Abuse and Addiction
Substance Abuse and Addiction
 
Escaping the temptations of Drub abuse
Escaping the temptations of Drub abuseEscaping the temptations of Drub abuse
Escaping the temptations of Drub abuse
 
Mod 7 drugs
Mod 7 drugsMod 7 drugs
Mod 7 drugs
 
Drug addiction, Criminal justice & Human Rights
Drug addiction, Criminal justice & Human RightsDrug addiction, Criminal justice & Human Rights
Drug addiction, Criminal justice & Human Rights
 
Drugs
DrugsDrugs
Drugs
 
Substances use and addictive disorders overview
Substances use  and addictive disorders overview Substances use  and addictive disorders overview
Substances use and addictive disorders overview
 
Substance abuse assignment
Substance abuse assignmentSubstance abuse assignment
Substance abuse assignment
 
Understanding Substance Use Disorder
Understanding Substance Use DisorderUnderstanding Substance Use Disorder
Understanding Substance Use Disorder
 
Understanding susbstance use disorder
Understanding susbstance use disorderUnderstanding susbstance use disorder
Understanding susbstance use disorder
 
Understanding susbstance use disorder
Understanding susbstance use disorderUnderstanding susbstance use disorder
Understanding susbstance use disorder
 
1
11
1
 

Kürzlich hochgeladen

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Kürzlich hochgeladen (20)

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 

Drug Abuse and Addiction

  • 1. DRUG ABUSE GROUP MEMBERS: AHMAD ABID ABAS [2] AHMAD ASYRAF MOHAMAD [3] AHMAD DANIAL AHMAD FUAD [5] AHMAD FARABI AB MANAF [7] ADIBA MD ZAIN [8] ADIBAH ABDUL JABAR [9] KHAIREZA KHAIRUDIN [10] ASIF AMRI HUSSIN [11]
  • 2. BY:ASIF AMRI BIN HUSSIN (07-5-11)
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. This map shows the Malaysia and it’s states.
  • 12. The following table illustrates the number of drug abuse in Malaysia by states from January to June 2011 and the differences in the number for the same period during 2010.
  • 13. This table shows the number of drug abuser in Malaysia from January to June 2011 and the differences of the numbers in the same months from the last year.
  • 14.
  • 15.
  • 16. The table above shows the number of drug abuser according to the job and the differences in number compared to 2010 statistics.
  • 17.  
  • 18.
  • 19.
  • 20. FACTORS ASSOCIATED WITH DRUG ABUSE by: AHMAD DANIAL BIN AHMAD FUAD,5
  • 21.
  • 22.  
  • 23.  
  • 24.
  • 25.
  • 26.
  • 27. The A1 allele of the dopamine receptor gene  DRD2  is more common in people addicted to alcohol or cocaine Increased expression of the  Mpdz  gene results in mice experiencing less severe withdrawal symptoms from sedative-hypnotic drugs such as barbiturates Mice bred to lack the cannabinoid receptor gene  Cnr1  have a reduced reward response to morphine . Mice bred to lack the serotonin receptor gene Htr1b  are more attracted to cocaine and alcohol Mice bred to lack the β2 subunit of nicotinic cholinergic receptors have a reduced reward response to cocaine Mice with low levels of neuropeptide Y drink more alcohol, whereas those with higher levels tend to abstain Fruit flies mutated to be unable to synthesize tyramine remain sedate even after repeated doses of cocaine Mice mutated with a defective Per2  gene drink three times more alcohol than normal Non-smokers are more likely than smokers to carry a protective gene,  CYP2A6 , which causes them to feel more nausea and dizziness from smoking Alcoholism is rare in people with two copies of the  ALDH*2  gene variation Mice with the  Creb  gene "knocked-out" are less likely to develop morphine dependence.
  • 28.
  • 29.
  • 30.  
  • 31.
  • 33. Cannabinoids and hallucinogens By: Ahmad Asyraf bin Mohamed (3)
  • 34.
  • 35.  
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 43.
  • 44.
  • 45.  
  • 46.
  • 47.
  • 48.
  • 49.
  • 50. AMPHETAMINES ADDICTION By : ADIBAH ABDUL JABAR (9)
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.  
  • 56.
  • 57.  
  • 58.
  • 59. Tobacco and Inhalants Ahmad Abid Abas 2
  • 60.
  • 61.
  • 64.
  • 65. Malaysian Smoking Cessation Programme and Smoke-Free Air Laws
  • 66.
  • 67.  
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.  
  • 73.  
  • 74.  
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.  
  • 80.
  • 81.  
  • 82.
  • 83.  
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89. A blood toxicology screen can determine the presence and level (amount) of a drug in your body. Urine sample results are usually reported as positive (substance is found) or negative (no substance is found).
  • 90.
  • 91. DRUGS DURATION OF DETECTION IN URINE: Alcohol up to 1 day Amphetamines (including MDMA, MDA) 1-3 days Barbiturates 1-3 days Benzodiazepines 1-3 days Cannabis up to 14 days Cocaine 1-3 days Codeine 1-2 days Cyclizine 1-2 days Dihydrocodeine 1-2 days Heroin (morphine) up to 1 day Methadone 1-3 days 6-MAM up to 1 day
  • 92.
  • 93. PRINCIPLE AND METHODS OF TREATMENT BY: ADIBA MD ZAIN [8]
  • 94.
  • 95.
  • 96.
  • 97.  
  • 98.
  • 99.
  • 100.
  • 101.
  • 103.  
  • 104. Prepared By: AHMAD FARABI BIN AB MANAF (7) PHARMACOTHERAPY FOR ADDICTIVE DISORDER
  • 105.  
  • 106.
  • 107.
  • 108.
  • 109.  
  • 110.
  • 111.
  • 112.  
  • 113.
  • 114.
  • 115.
  • 116.